Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen by SICOS ET CIE Drug Facts

Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen by

Drug Labeling and Warnings

Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen by is a Otc medication manufactured, distributed, or labeled by SICOS ET CIE. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

YVES SAINT LAURENT ALL HOURS FOUNDATION FLAWLESS COVERAGE BROAD SPECTRUM SPF 20 SUNSCREEN- octinoxate lotion 
SICOS ET CIE

----------

Drug Facts

Active ingredient

Octinoxate 3%

Purpose

Sunscreen

Uses

  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Flammable until dry.

Avoid fire, flame and heat during application.

Do not use

on damaged or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

rash occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

  • shake well before use
  • apply liberally 15 minutes before sun exposure
  • reapply at least every 2 hours
  • use a water resistant sunscreen if swimming or sweating
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  •                 limit time in the sun, especially from 10 a.m. - 2 p.m.
  •                 wear long-sleeved shirts, pants, hats and sunglasses
  • children under 6 months of age: Ask a doctor

Other information

  • protect the product in this container from excessive heat and direct sun

Inactive ingredients

water, cyclopentasiloxane, alcohol denat., isododecane, acrylates/polytrimethylsiloxymethacrylate copolymer, butylene glycol, glycerin, polymethylsilsesquioxane, cetyl PEG/PPG-10/1 dimethicone, synthetic fluorphlogopite, isohexadecane, polyglyceryl-4 isostearate, magnesium sulfate, disodium stearoyl glutamate, fragrance, perlite, saccharomyces/xylinum/black tea ferment, silica silylate, aluminum hydroxide, butyrospermum parkii (shea) seedcake extract, hydroxyethylcellulose, BHT, phenoxyethanol, sodium citrate, benzyl alcohol, linalool, citric acid, potassium sorbate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, biotin; may contain: titanium dioxide, iron oxides

image of a carton

image of a carton
image of a carton
image of a carton
YVES SAINT LAURENT ALL HOURS FOUNDATION FLAWLESS COVERAGE BROAD SPECTRUM SPF 20 SUNSCREEN 
octinoxate lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 51150-363
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate30 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
ALCOHOL (UNII: 3K9958V90M)  
ISODODECANE (UNII: A8289P68Y2)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)  
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) (UNII: V2W71V8T0X)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)  
MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB)  
DISODIUM STEAROYL GLUTAMATE (UNII: 45ASM2L11M)  
PERLITE (UNII: 0SG101ZGK9)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
LINALOOL, (+/-)- (UNII: D81QY6I88E)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)  
BIOTIN (UNII: 6SO6U10H04)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 51150-363-011 in 1 CARTON06/01/201702/16/2025
125 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC: 51150-363-02125 mL in 1 BOTTLE; Type 0: Not a Combination Product06/01/201712/30/2024
3NDC: 51150-363-031 in 1 CARTON06/01/201712/30/2024
310 mL in 1 BOTTLE; Type 0: Not a Combination Product
4NDC: 51150-363-041 in 1 CARTON06/01/201712/30/2024
45 mL in 1 BOTTLE; Type 0: Not a Combination Product
5NDC: 51150-363-051 mL in 1 PACKET; Type 0: Not a Combination Product06/01/201712/30/2024
6NDC: 51150-363-061.2 mL in 1 BLISTER PACK; Type 0: Not a Combination Product02/08/201912/30/2024
7NDC: 51150-363-071 in 1 CARTON07/30/202012/30/2024
78 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02006/01/201702/16/2025
Labeler - SICOS ET CIE (276993581)
Establishment
NameAddressID/FEIBusiness Operations
SICOS ET CIE276993581manufacture(51150-363) , pack(51150-363)

Revised: 6/2024
 <

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.